Medilink News Yorkshire & Humber - Autumn 2014 Autumn 2014 | Page 7

NEWS PRINCESS ANNE OPENS BRANDON MEDICAL’S NEW FACILITY SWITCHSTANCE SHOWCASES GROUNDBREAKING CLAHRC RESEARCH Healthcare software specialist, Switchstance has developed a partnership with the East of England Collaboration for Leadership in Applied Health Research and Care (CLAHRC EoE), to showcase the work of the CLAHRC and how it improves patient care. CLAHRC EoE’s undertakes world-class applied health research, focused on the needs of patients and support the translation of research evidence into practice in the NHS. Following a highly successful first phase, the CLAHRC programme has received funding for a further five years of worldclass research. The partnership between Switchstance and the CLAHRC addressed a need to record, measure and monitor the improvement of patient outcomes through applied health research, by the implementation of an online KPI system. Switchstance is currently extending the KPI system further and have also created a web portal to link together the CLAHRC’s key collaboration tools and web presence. Boost your business with funded digital support Switchstance is now an accredited provider of strategic digital advice through the Growth Voucher programme backed by the Government. The Government launched the £30 million programme to give small firms subsidised expert support. To find out how you can get involved, visit the Switchstance website: www.switchstanceit.com L @SwitchstanceIT CHINA BOOSTS RD BIOMED’S GLOBAL GROWTH RD Biomed has announced a Chinese distribution agreement for its reflux diagnostic tool Peptest. The deal with Hong Kong-based investment and trading company MAAB International will see Peptest launched in China by 2016. Peptest is the world’s first non-invasive diagnostic test for all forms of reflux disease. It measures the presence of the digestive enzyme pepsin in a clinical sample, such as saliva, which is a reliable marker for the reflux of gastric juice. Research has shown reflux is increasing in prevalence in China, with approximately 120 million adults suffering from heartburn and reflux symptoms. Under the exclusive three-year distribution agreement, MAAB International will be responsible for registering Peptest with Chinese regulatory body the China Food and Drug Administration (CFDA), with an official launch estimated in 2016 once licencing has been finalised. Through its partners in China, MAAB International has access to a nationwide network of sales and distribution channels. For more information about RD Biomed visit: www.rdbiomed.com L @peptest_reflux HRH the Princess Royal recently visited Medilink member Brandon Medical. The visit of Princess Anne was to mark the official opening of a new facility that will double the operating capacity at Brandon Medical. The Princess was also invited to Brandon’s state of the art visitor centre to test an impressive portfolio of products. This was followed by a tour of the factory before the final grand plaque unveiling. The innovative centre features a demonstration operating theatre, ICU and GP Surgery. These additions will see the company showcase its OT lighting, examination lighting and medical architectural systems in a more realistic setting. Brandon Medical’s focus is to consolidate the design, production and sales of its medical equipment into one location, which will create more jobs in the local area. Graeme Hall, Managing Director of Brandon Medical said: “It was a joy to welcome Princess Anne to Brandon Medical. We enjoyed the opportunity to demonstrate how our technologies are improving the everyday lives of healthcare professionals across the globe and how our achievements have allowed us to relocate to such a fantastic new facility.” For more information on Brandon Medical visit: ww.brandon-medical.com L @BrandonMedical 07